CIK: 0001475373 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Aug 5, 2022
Total Value ($000): $446,954 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GILD | GILEAD SCIENCES INC | 843,427 | $52,132 | 11.7% | $54.51 | -0.8% | COM | 375558103 |
| MRK | MERCK & CO INC | 414,338 | $37,775 | 8.5% | $66.44 | +19.2% | COM | 58933Y105 |
| INCY | INCYTE CORP | 459,429 | $34,903 | 7.8% | $73.93 | +2.7% | COM | 45337C102 |
| MDT | MEDTRONIC PLC | 290,521 | $26,074 | 5.8% | $86.14 | +4.9% | SHS | G5960L103 |
| BMY | BRISTOL-MYERS SQUIBB CO | 311,696 | $24,001 | 5.4% | $44.65 | +45.5% | COM | 110122108 |
| CAH | CARDINAL HEALTH INC | 385,988 | $20,176 | 4.5% | $47.94 | +9.8% | COM | 14149Y108 |
| BSX | BOSTON SCIENTIFIC CORP | 532,735 | $19,855 | 4.4% | $31.53 | +29.1% | COM | 101137107 |
| BIIB | BIOGEN INC | 92,497 | $18,864 | 4.2% | $278.05 | -26.5% | COM | 09062X103 |
| CI | CIGNA CORP NEW | 66,283 | $17,467 | 3.9% | $207.88 | +16.1% | COM | 125523100 |
| ELV | ELEVANCE HEALTH INC | 34,300 | $16,552 | 3.7% | $253.78 | +85.0% | COM | 036752103 |
| BRKR | BRUKER CORP | 251,042 | $15,755 | 3.5% | $52.55 | +15.2% | COM | 116794108 |
| CVS | CVS HEALTH CORP | 168,111 | $15,577 | 3.5% | $57.80 | +48.6% | COM | 126650100 |
| CNC | CENTENE CORP DEL | 181,799 | $15,382 | 3.4% | $63.95 | +29.9% | COM | 15135B101 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 135,749 | $14,262 | 3.2% | $115.63 | -0.7% | COM | 98956P102 |
| — | NUVASIVE INC | 247,502 | $12,167 | 2.7% | $56.60 | — | COM | 670704105 |
| OGN | ORGANON & CO | 356,089 | $12,018 | 2.7% | $27.05 | +9.1% | COMMON STOCK | 68622V106 |
| — | QIAGEN NV | 201,729 | $9,522 | 2.1% | $49.97 | — | SHS NEW | N72482123 |
| VRTX | VERTEX PHARMACEUTICALS INC | 33,474 | $9,433 | 2.1% | $213.52 | +25.4% | COM | 92532F100 |
| — | SEAGEN INC | 50,795 | $8,988 | 2.0% | $176.95 | — | COM | 81181C104 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 105,259 | $8,723 | 2.0% | $81.81 | -2.7% | COM | 09061G101 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42,844 | $6,249 | 1.4% | $152.35 | -6.9% | COM | 02043Q107 |
| IONS | IONIS PHARMACEUTICALS INC | 165,439 | $6,125 | 1.4% | $54.18 | -30.4% | COM | 462222100 |
| BIO | BIO RAD LABS INC | 11,785 | $5,834 | 1.3% | $203.83 | +155.5% | CL A | 090572207 |
| ABT | ABBOTT LABS | 49,205 | $5,346 | 1.2% | $106.10 | 0.0% | COM | 002824100 |
| PFE | PFIZER INC | 100,000 | $5,243 | 1.2% | $28.29 | +48.4% | COM | 717081103 |
| — | INTRA-CELLULAR THERAPIES INC | 80,843 | $4,615 | 1.0% | $61.19 | — | COM | 46116X101 |
| — | SAGE THERAPEUTICS INC | 118,476 | $3,827 | 0.9% | $51.01 | — | COM | 78667J108 |
| PTCT | PTC THERAPEUTICS INC | 84,864 | $3,400 | 0.8% | $38.32 | -8.5% | COM | 69366J200 |
| NVAX | NOVAVAX INC | 55,324 | $2,845 | 0.6% | $99.88 | -48.2% | COM NEW | 670002401 |
| VIR | VIR BIOTECHNOLOGY INC | 110,223 | $2,807 | 0.6% | $31.74 | -26.4% | COM | 92764N102 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 46,221 | $2,758 | 0.6% | $69.58 | -11.6% | COM | 90400D108 |
| UHS | UNIVERSAL HLTH SVCS INC | 27,077 | $2,727 | 0.6% | $139.48 | -11.9% | CL B | 913903100 |
| — | RIGEL PHARMACEUTICALS INC | 1,466,678 | $1,657 | 0.4% | $2.78 | — | COM NEW | 766559603 |
| QTRX | QUANTERIX CORP | 88,670 | $1,436 | 0.3% | $30.56 | -32.7% | COM | 74766Q101 |
| — | SOMALOGIC INC | 301,224 | $1,362 | 0.3% | $8.02 | — | CLASS A COM | 83444K105 |
| — | ATARA BIOTHERAPEUTICS INC | 123,713 | $964 | 0.2% | $9.29 | — | COM | 046513107 |
| EMBC | EMBECTA CORP | 5,246 | $133 | 0.0% | $25.42 | 0.0% | COMMON STOCK | 29082K105 |